Hepatitis B

Kyrgyzstan has zero rates on many virus diseases

Zero rates on many virus diseases can be observed in Kyrgyzstan. The Deputy Minister of Health Care Kubanychbek Choibekov stated today at a session of the committee on social policy.

Undefined

Meet the emerging world’s vaccine pioneers

Vaccines work wonders. They prevent disease from striking, which is better than treating it after the fact. They are also relatively cheap and easy to deliver. Yet millions of children do not get them. This has always been stunning to me. When we started the Gates Foundation 15 years ago, we assumed that all of the obvious steps were already being taken, and that we would have to go after the expensive or unproven solutions. In fact, delivering basic vaccines is still one of our top priorities.

Undefined

The world needs made-in-China vaccines, despite a recent spate of deaths

China’s ambition to become a major player in vaccines has hit a snag: the deaths of 17 newborn infants who had just received Chinese-made hepatitis B vaccines.

Undefined

Baby deaths not caused by Shenzhen firm's hepatitis B vaccine, say officials

Mainland health authorities do not believe hepatitis B vaccinations played a role in the deaths of 17 infants.

But Yu Jingjin, a department chief at the National Health and Family Planning Commission, said they would wait for the final autopsy reports before reaching a conclusive decision.

Concerns over the safety of hepatitis B vaccinations arose after four children died within 24 hours of receiving a shot made by Shenzhen-based Biokangtai Biological Products, all between December 13-19.

Undefined

Sudan: Vaccines Destroyed By Fire in West Darfur Capital

Substantial stocks of vaccines were destroyed in a fire that broke out in the early hours of Tuesday morning at the immunisation office in El Geneina, capital of West Darfur.

Mubarak Adam Abakar, director of immunisation in West Darfur told Radio Dabanga that the fire destroyed the entire stock kept in cold storage, including routine vaccinations.

Read the rest of the article here.

Undefined

New Chinese quality standards raise the risk of a hep B vaccine shortage

China's push to raise manufacturing standards was always likely to result in a few hiccups as companies raced to bring production plants into line with new regulations. And with the deadline for producers of injectables now having passed, it appears the hepatitis B vaccine market faces a tricky few months.

Undefined

China Investigates Vaccine Maker After Deaths of Infants

Health authorities in China are investigating one of the nation’s biggest vaccine makers after eight infants died in the past two months following injections that were meant to immunize them against hepatitis B.

The government said this week that it had suspended the use of millions of doses of a hepatitis B vaccine produced by the manufacturer, Shenzhen Kangtai Biological Products. Government inspectors have been sent to examine the company’s facilities.

Undefined

Wolters Kluwer Health adds meningitis B vaccine to drug reference

Wolters Kluwer Health announced on Thursday that information about the European meningitis B vaccine was included in its drug reference resource Lexicomp Online and Facts and Comparisons eAnswers.

Undefined

WHO Executive Board Meeting

Hosted by the World Health Organization (WHO).

From the WHO website:

Undefined

‘Remote-controlled’ vaccine delivery could eliminate need for booster jabs

Many vaccines, such as those for Hep A and B, HPV, MMR and rabies, need several booster doses to achieve maximal immunological protection. Booster doses add to the complexity of vaccine administration, especially when used in large vaccination campaigns in the developing world.

Undefined

Pages